Tender for Health Services in Genetic Testing 2025-GEN-1
About This Opportunity
TranslatedThis tender announces a call for offers for the provision of health services specifically related to genetic testing, designated under the reference 2025-GEN-1. The procuring entity is seeking qualified healthcare providers or laboratories capable of performing a range of genetic diagnostic tests. The scope of services likely includes sample collection, processing, analysis, and reporting of genetic information for diagnostic or screening purposes. The tender aims to secure specialized medical services to meet the healthcare needs of a defined patient population or for specific medical programs during the 2025 period. Potential bidders are expected to demonstrate their expertise in genetic analysis, adherence to relevant medical and laboratory standards (e.g., ISO, CLIA), and the capacity to handle the anticipated volume of tests. The tender documents will detail the specific types of genetic tests required, the expected quality standards, reporting formats, turnaround times, and contractual obligations. This procurement is crucial for ensuring access to advanced diagnostic capabilities within the healthcare system.
This is a services contract in the health and medical services sector, with a focus on Laboratory. Located in Poland, Europe, this opportunity is open to firms and consortiums.
Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the health and medical services sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PolishThis tender, announced in Poland, seeks to procure a comprehensive range of healthcare services specifically focused on genetic testing for the period of 2025. The contracting authority, managed by the Publications Office of the European Union, is inviting qualified entities to submit offers for the provision of these specialized medical examinations.
The procurement is for a service contract, aiming to establish partnerships with providers capable of delivering high-quality genetic research and diagnostic services. Potential bidders are expected to possess the necessary accreditations, technical expertise, and laboratory infrastructure to conduct a variety of genetic tests. Typical requirements for such tenders often include adherence to stringent quality control standards, compliance with national and international regulatory frameworks governing healthcare and genetic testing, and the ability to deliver timely and accurate results.
Furthermore, bidders may be required to demonstrate experience in handling sensitive patient data, ensuring confidentiality and data security in line with relevant data protection laws. The scope of services could encompass a broad spectrum of genetic analyses, potentially including diagnostic testing for hereditary diseases, pharmacogenomic testing, prenatal genetic screening, and advanced genomic sequencing services. The objective is to secure reliable and advanced genetic testing capabilities to support healthcare initiatives within Poland.
Data provenance
This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on March 10, 2026. Last refreshed 14 days ago. Original language: Polish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Beskidzkie Centrum Onkologii - Szpital Miejski im. J. Pawła II w Bielsku -Białej
Beskidzkie Centrum Onkologii - Szpital Miejski im. J. Pawła II w Bielsku -Białej has issued 2 procurement notices on BidsFactory, including 0 currently open and 1 awarded contracts. Activity concentrates in Health & Medical. All notices are published for Poland. Notices are distributed via TED - Tenders Electronic Daily (EU). Most recent publication: March 10, 2026.
Frequently asked questions about this tender
What type of contract is this?
This is a Services contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
How much was the contract awarded for?
Diagnostyka Oncogene Sp. z o.o. was awarded the contract for €6,660,002. The figure reflects the value disclosed by the contracting authority in the award notice.
Where will the contract be performed?
The contract is for delivery in Poland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to Diagnostyka Oncogene Sp. z o.o.. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Beskidzkie Centrum Onkologii - Szpital Miejski im. J. Pawła II w Bielsku -Białej in Poland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.
Sectors & Categories
Contracting Authority
Companies That Won Similar
Companies with awards in Health & Medical in Poland